Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
Clinical trial NCT00283244 · COMPLETED
Trial details
- NCT number
- NCT00283244
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2014-09-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.